DAWN - Day One Biopharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DAWN is currently covered by 8 analysts with an average price target of $25.81. This is a potential upside of $17.5 (210.59%) from yesterday's end of day stock price of $8.31.

Day One Biopharmaceuticals's activity chart (see below) currently has 20 price targets and 59 ratings on display. The stock rating distribution of DAWN is 95.35% BUY, 2.33% SELL and 2.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 2.78% with an average time for these price targets to be met of 75.33 days.

Highest price target for DAWN is $43, Lowest price target is $25, average price target is $34.33.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 05-Mar-2025.

Currently out of the existing stock ratings of DAWN, 41 are a BUY (95.35%), 1 are a SELL (2.33%), 1 are a HOLD (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$34

$25.77 (313.12%)

$36

19 days ago
(05-Mar-2025)

0/4 (0%)

$24.3 (250.52%)

Buy

$32

$23.77 (288.82%)

$32

26 days ago
(26-Feb-2025)

0/8 (0%)

$22.13 (224.21%)

Buy

$32

$23.77 (288.82%)

$33

26 days ago
(26-Feb-2025)

0/16 (0%)

$22.13 (224.21%)

Buy

$43

$34.77 (422.48%)

$44

1 months 14 days ago
(10-Feb-2025)

0/5 (0%)

$31.13 (262.26%)

Buy

$25

$16.77 (203.77%)

$24

2 months 17 days ago
(07-Jan-2025)

1/4 (25%)

$12.6 (101.61%)

678

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DAWN (Day One Biopharmaceuticals) average time for price targets to be met?

On average it took 75.33 days on average for the stock forecasts to be realized with a an average price target met ratio 2.78

Which analyst has the current highest performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on DAWN (Day One Biopharmaceuticals)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on DAWN

Which analyst is the currently most bullish on DAWN (Day One Biopharmaceuticals)?

Andrea Tan with highest potential upside - $34.77

Which analyst is the currently most reserved on DAWN (Day One Biopharmaceuticals)?

Marc Frahm with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?